1,311
Views
53
CrossRef citations to date
0
Altmetric
Report

Scleroderma-like properties of skin from caveolin-1-deficient mice

Implications for new treatment strategies in patients with fibrosis and systemic sclerosis

Pages 2140-2150 | Published online: 01 Jul 2011

References

  • Jimenez SA, Derk CT. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140:37 - 50
  • LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: A possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974; 54:880 - 889
  • Jimenez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J 1986; 237:837 - 843
  • Jimenez SA, Bashey RI. Collagen synthesis by scleroderma fibroblasts in culture. Arthritis Rheum 1977; 20:902 - 903
  • Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103:359 - 363
  • Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200:500 - 503
  • Jimenez SA, Hitraya E, Varga J. Pathogenesis of scleroderma. Collagen. Rheum Dis Clin North Am 1996; 22:647 - 674
  • Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K, et al. Targeted disruption of TGF{beta}/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 2004; 165:203 - 217
  • Fleischmajer R, Gay S, Meigel WN, Perlish JS. Collagen in the cellular and fibrotic stages of scleroderma. Arthritis Rheum 1978; 21:418 - 428
  • Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997; 136:729 - 743
  • Dombi GW, Haut RC, Sullivan WG. Correlation of high-speed tensile strength with collagen content in control and lathyritic rat skin. J Surg Res 1993; 54:21 - 28
  • Brady AH. Collagenase in scleroderma. J Clin Invest 1975; 56:1175 - 1180
  • Jimenez SA. Cellular immune dysfunction and the pathogenesis of scleroderma. Semin Arthritis Rheum 1983; 13:104 - 113
  • Kraling BM, Maul GG, Jimenez SA. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology 1995; 63:48 - 56
  • Severs NJ. Caveolae: Static inpocketings of the plasma membrane, dynamic vesicles or plain artifact?. J Cell Sci 1988; 90:341 - 348
  • Razani B, Woodman SE, Lisanti MP. Caveolae: From cell biology to animal physiology. Pharmacol Rev 2002; 54:431 - 467
  • Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001; 276:38121 - 38138
  • Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, et al. Loss of caveolae, vascular dysfunction and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001; 293:2449 - 2452
  • Del Galdo F, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, et al. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum 2008; 58:2854 - 2865
  • Tourkina E, Gooz P, Pannu J, Bonner M, Scholz D, Hacker S, et al. Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem 2005; 280:13879 - 13887
  • Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, Liu F, et al. Caveolin-1: A critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 2006; 203:2895 - 2906
  • Martinez-Outschoorn UE, Trimmer C, Lin Z, Whitaker-Menezes D, Chiavarina B, Zhou J, et al. Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment. Cell Cycle 2010; 9:3515 - 3533
  • Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol 2006; 146:362 - 370
  • Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, et al. Oxidative stress in scleroderma: Maintenance of scleroderma fibroblast phenotype by the constitutive upregulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44:2653 - 2664
  • Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, et al. The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle 2010; 9:3485 - 3505
  • Sahoo PK, Soltani S, Wong AKC, Chen YC. A survey of thresholding techniques. Comput Vision Graph Image Process 1988; 41:233 - 260
  • Beucher S, Lantuéjoul C. Use of watersheds in contour detection. International workshop on image processing, real-time edge and motion detection 1979; France
  • Derwin KA, Soslowsky LJ, Green WD, Elder SH. A new optical system for the determination of deformations and strains: calibration characteristics and experimental results. J Biomech 1994; 27:1277 - 1285
  • Favata M. Scarless Healing in the fetus: Implications and strategies for postnatal tendon repair 2006; Ph.D., Dissertation Philadelphia University of Pennsylvania
  • Christner PJ, Gentiletti J, Peters J, Ball ST, Yamauchi M, Atsawasuwan P, et al. Collagen dysregulation in the dermis of the Sagg/+ mouse: A loose skin model. J Invest Dermatol 2006; 126:595 - 602
  • Fry P, Harkness ML, Harkness RD. Mechanical Properties of the collagenous framework of skin in rats of different ages. Am J Physiol 1964; 206:1425 - 1429
  • Keiser HR, Stein HD, Sjoerdsma A. Increased protocollagen proline hydroxylase activity in sclerodermatous skin. Arch Dermatol 1971; 104:57 - 60
  • Fleischmajer R, Perlish JS, Krieg T, Timpl R. Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 1981; 76:400 - 403
  • Meyringer R, Neumann E, Judex M, Landthaler M, Kullmann F, Scholmerich Jr, et al. Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display. J Rheumatol 2007; 34:747 - 753
  • Del Galdo F, Lisanti MP, Jimenez SA. Caveolin-1, transforming growth factor-beta receptor internalization and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2008; 20:713 - 719
  • Hayes RL, Rodnan GP. The ultrastructure of skin in progressive systemic sclerosis (scleroderma). I. Dermal collagen fibers. Am J Pathol 1971; 63:433 - 442
  • Fleischmajer R, Damiano V, Nedwich A. Scleroderma and the subcutaneous tissue. Science 1971; 171:1019 - 1021
  • Rosenbloom J, Harsch M, Jimenez S. Hydroxyproline content determines the denaturation temperature of chick tendon collagen. Arch Biochem Biophys 1973; 158:478 - 484
  • Walmsley AR, Batten MR, Lad U, Bulleid NJ. Intracellular retention of procollagen within the endoplasmic reticulum is mediated by prolyl 4-hydroxylase. J Biol Chem 1999; 274:14884 - 14892
  • Kawaguchi Y, Kitani A, Hara M, Harigai M, Hirose T, Suzuki K, et al. Cytokine regulation of prolyl-4-hydroxylase production in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis. J Rheumatol 1992; 19:1195 - 1201
  • Kawaguchi Y, Harigai M, Kitani A, Suzuki K, Kawakami M, Ishizuka T, et al. Effect of prolyl 4-hydroxylase inhibitor on fibroblast collagen production in vitro: An approach to the treatment of systemic sclerosis. J Rheumatol 1992; 19:1710 - 1715
  • Uitto J, Halme J, Hannuksela M, Peltokallio P, Kivirikko KI. Protocollagen proline hydroxylase activity in the skin of normal human subjects and of patients with scleroderma. Scand J Clin Lab Invest 1969; 23:241 - 247
  • Knight LR, Smeathers JE, Isdale AH, Helliwell PS. Evaluating the cutaneous involvement in scleroderma: Torsional stiffness revisited. Rheumatology 2001; 40:128 - 132
  • Sappino AP, Masouye I, Saurat JH, Gabbiani G. Smooth muscle differentiation in scleroderma fibroblastic cells. Am J Pathol 1990; 137:585 - 591
  • Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum 2006; 54:3655 - 3660
  • Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC, et al. Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: A transcriptional informatics analysis with validation. Cell Cycle 2010; 9
  • Vincent AS, Phan TT, Mukhopadhyay A, Lim HY, Halliwell B, Wong KP. Human skin keloid fibroblasts display bioenergetics of cancer cells. J Invest Dermatol 2008; 128:702 - 709
  • Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Bonnet S, et al. An abnormal mitochondrial-hypoxia inducible factor-1{alpha}-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: Similarities to human pulmonary arterial hypertension. Circulation 2006; 113:2630 - 2641

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.